Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.६३%
१,१०३.६२
+६.९०
+०.६३%
१,०९२.७४१,०९५.९५१,१०३.३२१,०९४.७२
SIXC
Communications
SIXC
Communications
SIXC
-०.५३%
६०८.०५
-३.२७
-०.५३%
६१३.३६६१३.३६६१३.३६६०९.५०
SIXE
Energy
SIXE
Energy
SIXE
+१.२२%
१,१८५.८४
+१४.३०
+१.२२%
१,१७६.७९१,१७६.५२१,१८२.२५१,१६६.६९
SIXI
Industrials
SIXI
Industrials
SIXI
+०.००%
१,७४७.६८
+०.०५०
+०.००%
१,७५५.५४१,७५९.२३१,७६६.३०१,७४६.०४
SIXM
Financials
SIXM
Financials
SIXM
+०.१०%
६३२.१३
+०.६४
+०.१०%
६३५.१५६३५.२०६३६.८९६३०.०९
SIXR
Staples
SIXR
Staples
SIXR
-०.०६%
८४९.४०
-०.५४
-०.०६%
८४८.०१८५२.५२८५५.७८८४९.५८
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.३८%
२१८.८८
+०.८२
+०.३८%
२१७.८६२१७.८६२१९.५२२१७.८६
SIXT
Technology
SIXT
Technology
SIXT
+०.२५%
३,५४४.७४
+८.७१
+०.२५%
३,४१७.३५३,४५२.७७३,५३६.०३३,४५०.३९
SIXU
Utilities
SIXU
Utilities
SIXU
+१.००%
९१४.०९
+९.०२
+१.००%
९१३.३६९१५.१०९२०.४३९०४.५७
SIXV
Health care
SIXV
Health care
SIXV
+०.३१%
१,४५४.३२
+४.४६
+०.३१%
१,४६२.३८१,४६१.१३१,४६४.५३१,४४६.०२
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.७३%
२,४१२.७३
-१७.७४
-०.७३%
२,४२३.१४२,४२८.७१२,४४८.६९२,४२४.६३
ALNOV:EPA
Novacyt SA
€ ०.९०
+६८.०३%
(+०.३७) 1D
मे ११, १५:२४:३९ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALNOV...
Open
€ ०.६८
High
€ ०.९०
Low
€ ०.६४
Mkt. cap
६.२८ करोड
Avg. vol.
२.७८ लाख
Volume
१.१५ करोड
52-wk high
€ ०.९०
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२१६
News stories
From sources across the web
marketscreener.com
marketscreener.com
·
६ मिनेट पहिले
Wall St slips at open as US-Iran impasse lifts oil
The Manila Times
The Manila Times
·
११ मिनेट पहिले
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees२१६
Founded२००६ जुलाई ३
Headquarters-
Sector-
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
४८.९६ लाख
४८.९६ लाख
५१.१८ लाख
५१.१८ लाख
Cost of goods sold
१६.४३ लाख
१६.४३ लाख
२०.६४ लाख
२०.६४ लाख
Cost of revenue
१६.४३ लाख
१६.४३ लाख
२०.६४ लाख
२०.६४ लाख
Research and development expenses
१०.२२ लाख
१०.२२ लाख
१०.३४ लाख
१०.३४ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.०८ लाख
५५.०८ लाख
५२.३८ लाख
५२.३८ लाख
Operating expense
६४.३२ लाख
६४.३२ लाख
१.४१ करोड
१.४१ करोड
Total operating expenses
८०.७५ लाख
८०.७५ लाख
१.६२ करोड
१.६२ करोड
Operating income
-३१.७८ लाख
-३१.७८ लाख
-१.११ करोड
-१.११ करोड
Other non operating income
-३१.०० हजार
-३१.०० हजार
२६.७४ लाख
२६.७४ लाख
EBT including unusual items
-३५.१३ लाख
-३५.१३ लाख
-१.०२ करोड
-१.०२ करोड
EBT excluding unusual items
-३१.२० लाख
-३१.२० लाख
-१.०६ करोड
-१.०६ करोड
Income tax expense
-१.३४ लाख
-१.३४ लाख
-१८.१४ लाख
-१८.१४ लाख
Effective tax rate
३.८०%
३.८०%
१७.८५%
१७.८५%
Other operating expenses
-९७.५० हजार
-९७.५० हजार
७८.५५ लाख
७८.५५ लाख
Net income
-३१.७१ लाख
-३१.७१ लाख
-८२.७० लाख
-८२.७० लाख
Net profit margin
-६४.७६%
-६४.७६%
-१६१.६०%
-१६१.६०%
Earnings per share
-
-
-
-
Interest and investment income
१.७७ लाख
१.७७ लाख
-
-
Interest expense
-१.५४ लाख
-१.५४ लाख
-२०.८६ लाख
-२०.८६ लाख
Net interest expenses
२३.०० हजार
२३.०० हजार
-२०.८६ लाख
-२०.८६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२१.६६ लाख
-२१.६६ लाख
-२८.०४ लाख
-२८.०४ लाख
Gain or loss from assets sale
-१.४८ लाख
-१.४८ लाख
-३.०० हजार
-३.०० हजार
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more